Anlageziel BNY Mellon Smart Cures Innovation Fund USD A Acc Fonds
The Sub-Fund aims to achieve long-term capital growth and has a sustainable investment objective. Specifically, the Sub-Fund aims to contribute to a social objective by investing in securities of companies located worldwide that improve the adequacy and efficiency of health systems through innovation in biotechnology and healthcare.
Stammdaten
| Valor | 59015949 |
| ISIN | IE00BLB0VD50 |
| Fondsgesellschaft | BNY Mellon Fund Management |
| Kategorie | Branchen: Gesundheitswesen |
| Währung | USD |
| Mindestanlage | 4’347.75 |
| VL-fähig? | Nein |
| Thesaurierend/Ausschüttend | Thesaurierend |
| Fondsmanager | Edward Walter, Matthew Jenkin |
Aktuelle Daten
| Fondsnote | |
| Aktueller Rücknahmepreis | 0.66 |
| Fondsvolumen | 18’498’223.75USD |
| Total Expense Ratio (TER) | 1.98% |
Gebühren
| Verwaltungsgebühr | - |
| Depotbankgebühr | - |
| Rücknahmegebühr | 0.00 % |
| Ausgabeaufschlag | 5.00 % |